Investors Land OCX Even Cheaper Than Its Secondary Stock Offering

Looking back to 25 days ago, OncoCyte Corp (OCX) priced a 7,780,000 share secondary stock offering at $4.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..